Product Information
KERENDIA 40 MG TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $22.8957 per EA under NDC 50419054202. Its NADAC has been published 27 times since Feb 18, 2026.
FDA first approved this application on Jul 9, 2021.
Strength
40 mg/1
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419054202
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FINERENONEApproval Type
New Drug (NDA)
FDA Application
NDA215341FDA Approved
7/9/2021
On Market Since
7/9/2021
Pharmacological Classes
Price Statistics
The NADAC for KERENDIA 40 MG TABLET has been published 27 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.8957 per EA |
|---|---|
| All-time high | $22.8957 (Aug 19, 2026) |
| All-time low | $22.8604 (Feb 18, 2026) |
| 52-week high | $22.8957 |
| 52-week low | $22.8604 |
| Median price | $22.8812 |
| Average price | $22.8735 |
| Largest weekly change | +0.1% (May 20, 2026) |
| Weeks tracked | 27 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KERENDIA 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KERENDIA 40 MG TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $22.8957 per EA (NDC 50419054202), effective Aug 19, 2026.
How has the price of KERENDIA 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for KERENDIA 40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 27 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for KERENDIA 40 MG TABLET?
Since Feb 18, 2026, the NADAC for KERENDIA 40 MG TABLET has ranged from a low of $22.8604 (Feb 18, 2026) to a high of $22.8957 (Aug 19, 2026), with a median of $22.8812 per EA.
Are there cheaper alternatives to KERENDIA 40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KERENDIA 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures KERENDIA 40 MG TABLET?
KERENDIA 40 MG TABLET (NDC 50419054202) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.